Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brendan D. Manning
Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
Cancer Cell
Cancer Research
Oncology
Cell Biology
The TSC1–TSC2 Complex: A Molecular Switchboard Controlling Cell Growth
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Related publications
Personalized Medicine: Exploiting Druggable Vulnerabilities for KRAS-driven Lung Cancer
Oncoscience
Cancer Research
Oncology
A Small Molecule Approach to Degrade RAS With EGFR Repression Is a Potential Therapy for KRAS Mutation-Driven Colorectal Cancer Resistance to Cetuximab
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Exploiting SCADA Vulnerabilities Using a Human Interface Device
International Journal of Advanced Computer Science and Applications
Computer Science
MA27.10 EGFR-Targeted Therapy Alters the Tumor Microenvironment in EGFR-Driven Lung Tumors: Rationale for Combination Therapies
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy
Journal of Nanomedicine & Nanotechnology
mRNA Splicing Variants: Exploiting Modularity to Outwit Cancer Therapy
Cancer Research
Cancer Research
Oncology
Exploiting Theory to Develop Practice in Biological Education
Journal of Biological Education
Agricultural
Education
Biological Sciences
Targeting Ras-Driven Cancer Cell Survival and Invasion Through Selective Inhibition of DOCK1
Cell Reports
Biochemistry
Genetics
Molecular Biology
Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK
Clinical Cancer Research
Cancer Research
Oncology